Hippocratic AI key facts
as of Oct 2026- Developer of a healthcare platform intended to improve healthcare accessibility and health outcomes worldwide.
- Hippocratic AI is valued at approximately $3.5B as of Oct 2026 (last reported valuation).
- It has raised $404.0M; the latest was Later Stage VC ($126.0M) in Nov 2025.
- Notable investors include Andreessen Horowitz, General Catalyst, SV Angel, Greycroft, Kleiner Perkins — 26 tracked in total.
- Status: Privately Held (backing).
Hippocratic AI's last reported valuation, Nov 2025. Nothing priced has surfaced since.
- ·The complete investor list: 26 names
- ·Watch Hippocratic AI: the Monday email on marks, rounds and moves
Hippocratic AI funding rounds
No funding rounds for Hippocratic AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Hippocratic AI
26+Hippocratic AI valuation
Hippocratic AI's last reported valuation was $3.5 billion in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.
Hippocratic AI investors
26 investors are on record for Hippocratic AI, including Andreessen Horowitz, General Catalyst, SV Angel and Greycroft. By type, the record holds 9 venture capital firms and 4 growth equity firms.
About Hippocratic AI
Developer of a healthcare platform intended to improve healthcare accessibility and health outcomes worldwide. The company's platform helps develop safe artificial health general intelligence to improve healthcare accessibility and fitness outcomes, enabling patients to get healthcare at home and improve their health without any hassle
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 2023
- Employees
- 190
- Website
- hippocraticai.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.